Hem › Neuroblastom › Georgia
Kliniska studier för Neuroblastom i Georgia
9 studier för Neuroblastom söker deltagare vid platser i Georgia.
Städer i Georgia
Officiell studietext (engelska)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
- Memorial Health University Medical Center, Savannah
RekryterarFas 3
Upp till ålder 30 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Augusta University Health, Augusta
RekryterarFas 2
Upp till ålder 22 · Alla kön · Uppdaterad 4 sep. 2026 · NCT02559778Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
- Memorial Health University Medical Center, Savannah
RekryterarFas 3
365 Days – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Augusta University Health, Augusta
RekryterarFas 2
12 Months – 21 Years · Alla kön · Uppdaterad 12 aug. 2026 · NCT05489887Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 19 maj 2026 · NCT04901702Neuroblastoma Biology Study
- AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta
RekryterarObservationsstudie
31 Days – 99 Years · Alla kön · Uppdaterad 23 mars 2026 · NCT01587300Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Children's Healthcare of Atlanta, Atlanta
Rekryterar
Upp till ålder 17 · Alla kön · Uppdaterad 10 feb. 2026 · NCT06831552Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
- Children's Healthcare of Atlanta, Atlanta
RekryterarFas 1
12 Months · Alla kön · Uppdaterad 26 dec. 2025 · NCT05400603Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.